FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Endovascular Graft, Aortic Aneurysm Treatment

PMA: P100040 · Supplement: S012 · Decision Jan 22, 2014
Classifications
1
FEI Numbers
34
Registration Numbers
34

Basic Information

Device Name
System, Endovascular Graft, Aortic Aneurysm Treatment
Trade Name
VALIANT THORACIC STENT GRAFT WITH CAPTIVIA DELIVERY SYSTEM
PMA Number
P100040
Supplement Number
S012
Device Class
FDA Class 3
Product Code
MIH
Generic Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
January 22, 2014
Date Received
July 29, 2013
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N
Docket Number
14M-167

Advisory Committee Statement

APPROVAL FOR THE VALIANT THORACIC STENT GRAFT WITH CAPTIVIA DELIVERY SYSTEM (VALIANT CAPTIVIA). THIS DEVICE IS INDICATED FOR THE ENDOVASCULAR REPAIR OF ALL LESIONS OF THE DESCENDING THORACIC AORTA (DTA) IN PATIENTS HAVING THE APPROPRIATE ANATOMY INCLUDING: 1) ILIAC OR FEMORAL ARTERY ACCESS VESSEL MORPHOLOGY THAT IS COMPATIBLE WITH VASCULAR ACCESS TECHNIQUES, DEVICES OR ACCESSORIES; NONANEURYSMAL AORTIC DIAMETER IN THE RANGE OF 18 MM TO 42 MM (FUSIFORM AND SACCULAR ANEURYSMS/PENETRATING ULCERS), OR 18 MM TO 44 MM (BLUNT TRAUMATIC AORTIC INJURIES), OR 20 MM TO 44 MM (DISSECTIONS); AND NONANEURYSMAL AORTIC PROXIMAL AND DISTAL NECK LENGTHS ¿ 20 (FUSIFORM AND SACCULAR ANEURYSMS/ PENETRATING ULCERS), LANDING ZONE ¿20 MM PROXIMAL TO THE PRIMARY ENTRY TEAR (BLUNT TRAUMATIC AORTIC INJURIES, DISSECTIONS). THE PROXIMAL EXTENT OF THE LANDING ZONE MUST NOT BE DISSECTED.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MIH System, Endovascular Graft, Aortic Aneurysm Treatment